The CPT code description selected by the Panel is "Ablation of malignant prostate tissue, transrectal, with high intensity focused ultrasound including ultrasound guidance." The code will be included in the next CPT Codebook and be effective on January 1, 2021.
Symptomatic seminal vesicle cysts may require interventional treatment, which may be by minimally invasive surgery, or an approach through natural orifices (transrectal aspiration and transurethral resection), or open surgery.
Compared with the standard transrectal ultrasound-guided sextant biopsy, MRI-targeted biopsies detect more intermediate/high-risk cancer using fewer biopsy cores and reduce overdetection of low-risk cancer.
Within the last few decades, the prevalence of transrectal ultrasound-guided prostate biopsies (TRUS-bx) has increased worldwide owing to the use of prostate-specific antigen (PSA) for screening of prostate cancer (PCa) (1,2).